SPA
TSVT

Sherbrooke Park Advisers’s 2seventy bio TSVT Stock Holding History

Sherbrooke Park Advisers’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,864
Closed -$93.2K – 781
2025
Q1 		$93.2K Sell
18,864
-15,884
-46% -$50.5K 0.04% 521
2024
Q4 		$102K Sell
34,748
-4,102
-11% -$16.8K 0.03% 667
2024
Q3 		$183K Sell
38,850
-16,172
-29% -$72.9K 0.04% 772
2024
Q2 		$212K Buy
55,022
+43,046
+359% +$194K 0.04% 751
2024
Q1 		$64.1K Sell
11,976
-16,246
-58% -$76.4K 0.01% 813
2023
Q4 		$121K Sell
28,222
-29,210
-51% -$89.8K 0.06% 384
2023
Q3 		$225K Buy
+57,432
New +$377K 0.07% 374

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sherbrooke Park Advisers's TSVT Position: Q2 2025 in Review

Sherbrooke Park Advisers sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 18,864 shares — an estimated $93.2K sold.

Sherbrooke Park Advisers first reported a position in TSVT in Q3 2023 and held it in 7 quarters. The position peaked at $225K in Q3 2023. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Sherbrooke Park Advisers reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 18,864 2seventy bio shares in Q2 2025, an estimated $93.2K.
  • Sherbrooke Park Advisers first reported a position in 2seventy bio in Q3 2023 and held it in 7 quarters.
  • Sherbrooke Park Advisers's 2seventy bio position peaked at $225K in Q3 2023.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.